New high-purity prebiotic tackles challenging prebiotic applications like gummies that require higher ingredient payload

FrieslandCampina says its new Biotis GOS-OP High Purity ingredient is the now the highest-purity prebiotic it offers, at over 90% pure GOS.

Prebiotic ingredients can be difficult to formulate into delivery forms like gummies, tablets, and capsules due to the volume of active ingredient required for an efficacious dose, which can be challenging for those matrices to handle. Now, FrieslandCampina Ingredients (The Netherlands) is offering its highest-purity prebiotic ingredient yet, overcoming technical limitations of those delivery systems by reducing the amount of ingredient required. The ingredient targets digestive health.

The new Biotis GOS-OP High Purity ingredient contains 94% pure galacto-oligosaccharide (GOS) content‚ a level “significantly higher than the typical range for other prebiotics currently available,” the company’s press release states. The company says it is its highest-purity prebiotic to date and is created using a patent-pending process.

“Research has substantiated the efficacy of Biotis GOS-OP High Purity at doses as low as 2 g, enabling brands to easily create effective supplements that meet consumer needs,” the press release adds. Not only that, it says, “The process also results in a lower lactose content—less than 5%—supporting lower-lactose formulations which are increasingly popular with health-conscious consumers. In addition, Biotis GOS-OP High Purity has a long shelf-life, is highly heat and acid stable with optimal bulk density and particle size, and provides a clean sensory profile, supporting formulation in a range of appealing and compact supplement forms.”

In the press release, Sophie Zillinger Molenaar, global marketing lead for Biotis at FrieslandCampina Ingredients, said, “There’s a significant opportunity for innovation in gut health products, and while some consumers are turning to prebiotic-enriched foods, many are seeking convenient and novel supplement formats.”

Added Vicky Davies, global marketing director for performance, active, and medical nutrition at FrieslandCampina Ingredients, “The challenge for brands has been that, until now, the most desirable formats—like gummies, small powder sticks, capsules, and tablets—have been notoriously difficult to formulate with prebiotics. This is because the required dose of the active ingredient is challenging to formulate in a small format. So, we set out to change that.”